Polyunsaturated fatty acids and inflammatory bowel disease

American Journal of Clinical Nutrition

Volumn 71, Issue 1 SUPPL., 2000, Pages

  Belluzzi, Andrea ^a   Boschi, Stefano ^a   Brignola, Corrado ^a   Munarini, Alessandra ^a   Cariani, Giulio ^a   Miglio, Federico ^a  

^a NONE

Author keywords

Crohn disease; Fish oil; Inflammatory bowel disease; n 3 fatty acids; Polyunsaturated fatty acids; Review; Ulcerative colitis

Indexed keywords

FISH OIL; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID;

COLON CROHN DISEASE; CONFERENCE PAPER; DRUG EFFICACY; DRUG FORMULATION; ENTERITIS; HUMAN; PATIENT COMPLIANCE; PATIENT SELECTION; ULCERATIVE COLITIS;

EID: 0033955032     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/71.1.339s     Document Type: Conference Paper

References (27)

1. Lee TH, Hoover RL, Williams D, et al. Effect of a dietary enrichment with eicosapentaenoic acid and docosahexaenoic acids on in vitro polymorphonuclear and monocyte leukotriene generation and polymorphonuclear leukocyte function. N Engl J Med 1985;312:1217-24.
2. 4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 1984;86:453-60.
3. Rampton DS, Collins CE. Review article: thromboxanes in inflammatory bowel disease: pathogenic and therapeutic implications. Aliment Pharmacol Ther 1993;7:357-67.
4. Endres S, Ghorbani R, Kelly VE, et al. The effect of dietary supplementation with n-3 fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989;320:265-70.
5. Fisher M, Upchurch KS, Levine PH, et al. Effect of dietary fish oil supplementation on polymorphonuclear leucocyte inflammatory potential. Inflammation 1986;10:387-91.
6. Wakefield AJ, Sawyerr AM, Dhillon AP, et al. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 1989; 1:1057-62.
7. Webberley MJ, Hart MT, Melikian V. Thromboembolism in inflammatory bowel disease: role of platelets. Gut 1993;34:247-51.
8. Jaschoenek K, Clemens MR, Scheurlen M. Decreased responsiveness of platelets to a stable prostacyclin analogue in patients with Crohn's disease. Reversal by n-3 polyunsaturated fatty acids. Thromb Res 1991;63:667-72.
9. McCall TB, O'Leary D, Bloomfield J, et al. Therapeutic potential of fish oil in the treatment of ulcerative colitis. Aliment Pharmacol Ther 1989;3:415-24.
10. Salomon P, Asher A, Kornbluth, Janowitz HD. Treatment of ulcerative colitis with fish oil n-3 fatty acid: an open trial. J Clin Gastroenterol 1990;12:157-61.
11. Lorenz R, Weber PC, Szimnau P, Heldwein W, Strasser T, Loeschke K. Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease: a randomized, placebo-controlled, double-blind cross-over trial. J Intern Med 1989;225(suppl): 225-32.
12. Hawthorne AB, Daneshmend TK, Hawkey CJ, et al. Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut 1992;33:922-8.
13. Stenson WF, Cort D, Rodgers J, et al. Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med 1992;116: 609-14.
14. Asian A, Triadafilopoulos G. Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study. Am J Gastroenterol 1992;87:432-7.
15. Mate J, Castanos J, Garcia-Samaniego J, Pajares JM. Does dietary fish oil maintain the remission of Crohn's disease (CD): a study case control. Gastroenterology 1993:100:A-228(abstr).
16. Loeschke K, Ueberschaer B, Pietsch A, et al. n-3 Fatty acids retard early relapse in ulcerative colitis in remission. Dig Dis Sci 1996;41:2087-94.
17. Lorenz-Meyer H, Bauer P, Nicolay C, et al. Omega-3 fatty acids and carbohydrate diet for maintenance of remission in Crohn's disease. Scand J Gastroenterol 1996;31:778-85.
18. Brignola C, De Simone G, Belloli C, et al. Steroid treatment in active Crohn's disease: a comparison between two regimens of different duration. Aliment Pharmacol Ther 1994;8:465-8.
19. Budiarso IT. Fish oil versus olive oil. Lancet 1990;336:1313-4 (letter).
20. Petroni A, Blasevich M, Salami M, et al. Inhibition of platelet aggregation and eicosanoid production by phenolic components of olive oil. Thromb Res 1995;78:151-60.
21. Leventhal L, Boyce EG, Zurier RB. Treatment of rheumatoid arthritis with gammalinolenic acid. Ann Intern Med 1993;119:867-73.
22. Appel LJ, Miller ER, Seidler AJ, Whelton PK. Does supplementation of diet with "fish oil" reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med 1993;153:1429-38.
23. O'Connor GT, Malenka DJ, Olmstead EM, Johnson PS, Hennekens CH. A meta-analysis of randomized trials of fish oil in prevention of restenosis following coronary angioplasty. Am J Prev Med 1992;8:186-92.
24. Kunzel U, Bertsch S. Klinsche Erfahrungen mit einem standardiserten fischolkonzenntrat. Feldstudie mit 3.958 hyperlipamischen patienten in der praxis des niedergelassenen arztes. (Clinical results on the treatment of 3,958 patients with hyperlipidemia by using a concentrated fish oil preparation.) Fortschr Med 1990;108:437-42 (in German).
25. Belluzzi A, Brignola C, Campieri M, et al. Effects of a new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients. Dig Dis Sci 1994;39:2589-94.
26. Belluzzi A, Brignola C, Campieri M, et al. Effect of an entericcoated fish oil preparation on relapses in Crohn's disease. N Engl J Med 1996;334:1557-616.
27. Greenfield SM, Green AT, Teare JP, et al. A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis. Aliment Pharmacol Ther 1993;7:159-66.